This country profile provides an overview of Nigeria’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
62%
Blinding trachoma
30%
Intestinal worms
71%
Bilharzia
74%
River blindness
80%
101.89 million people received treatment in Nigeria in 2017 32.08 million people did not receive treatment in Nigeria in 2017

Priorities for progress in Nigeria

  • As the country bearing the biggest NTD burden in Africa, Nigeria is encouraged to further strengthenits preventive chemotherapy programme for all five diseases.
  • It should deliver systematic annual high-coverage implementation of all components, in all risk groups, as recommended by WHO.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage increased from 54% in 2016 to 62% in 2017.

People needing treatment
128.34m
People receiving treatment
79.83m

Blinding trachoma

Treatment coverage decreased from 37% in 2016 to 30% in 2017.

People needing treatment
19.87m
People receiving treatment
6.03m

Intestinal worms

Treatment coverage increased from 33% in 2016 to 71% in 2017.

Pre-sch and school-aged children needing treatment
46.75m
Pre-school and school-aged children receiving treatment
33.2m

Bilharzia

Treatment coverage increased from 57% in 2016 to 74% in 2017.

School-aged children needing treatment
16.83m
School-aged children receiving treatment
12.47m

River blindness

Treatment coverage increased from 67% in 2016 to 80% in 2017.

People needing treatment
49.9m
People receiving treatment
40.01m

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Nigeria.